Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
AssigneeCytos Pharmaceuticals LLC
InventorPeter G. Thomas
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for protecting the eye from degenerative eye conditions by administering prophylactic histidine compositions. The invention also relates to methods for treating ocular inflammation resulting from various causative agents, by administering therapeutic histidine compositions. The invention relates further still to novel histidine compositions for carrying out the present methods.
Claims45
A method for protecting a mammal from a degenerative eye condition comprising administering to a mammal suseptible to a degenerative eye condition a prophylactically effective amount of D-histidine, L-histidine, racemic or non-racemic mixtures of histidine, or pharmaceutically acceptable salts thereof.
A method for treating ocular inflammation associated with at least one of degenerative eye conditions, chronic eye conditions, a secondary sequela of primary disease, an infectious agent, an ophthalmic procedure, and unintentional eye trauma in a mammal comprising administering to said mammal a therapeutically effective amount of D-histidine, L-histidine, racemic or non-racemic mixtures of histidine, or pharmaceutically acceptable salts thereof.
A method for enhancing wound healing following a corneal excimer laser procedure comprising administering to a patient at a time comprising at least one of before, during, and after the corneal excimer laser procedure an amount of D-histidine, L-histidine, racemic or non-racemic mixtures of histidine, or pharmaceutically acceptable salts thereof effective to prevent a regrowth of non-planar keratocytes.
A composition for administration to an eye to treat ocular inflammatory conditions, comprising a therapeutically effective amount of D-histidine, L-histidine, racemic or non-racemic mixtures of histidine, or pharmaceutically acceptable salts thereof, an ophthalomological carrier therefor, and optionally, formulation adjuvants.
An eye cosmetic composition comprising a mascara, a liquid eyeliner, or an eye creme and an antiinflammation effective amount of D-histidine, L-histidine, racemic or non-racemic mixtures of histidine, or pharmaceutically acceptable salts thereof.
A method of preventing or treating corneal haze formation in an eye of a patient to undergo or having undergone laser-assisted photoablative surgical procedure causing a removal of corneal tissue, comprising administering to said patient at a time comprising before, during, or after said photoablative procedure an amount of D-histidine, L-histidine, racemic or non-racemic mixtures of histidine, or pharmaceutically acceptable salts thereof, effective to prevent or treat corneal haze formation.
Dependencies are inferred from the claim text.